- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Today, upon approval of the 2010 financial reports, the imec board confirmed that 2010 was a solid year. The board looks with confidence to the future. Imec's total revenue of 2010 amounted to 285 million euro. 42.7 million euro was granted to imec Belgium by the Flemish government, to guarantee imec's long term research and investment in new research initiatives, and imec the Netherlands at Holst Centre received 6.2 million euro from the Dutch government.
Imec's main driver is to provide the global industry nanoelectronics-based solutions and expertise to build excellent next-generation products based on shared innovation. In 2011 and beyond, imec will continue on the same path extending the scope of its research and business offering in the domains of energy, healthcare, ICT (information and communications technology), and imaging systems.
In 2010, imec employed 1,895 people, an 8% increase over 2009, including 336 residents - visiting researchers from partner companies and institutes - and 208 PhD students. The talent and devotion of imec's researchers led to important results, evidenced by about 1,800 conference contributions and publications in prestigious journals, often in collaboration with universities in Flanders and abroad. 143 patents were awarded in 2010 and a further 139 patents were submitted. Imec collaborates with over 600 companies and 175 universities worldwide.
"Imec has the ambition to be a pioneer in sustainable innovation, aiming at tackling the grand challenges the world is facing. I'm convinced that a major part of the answers for an efficient and sustainable healthcare system, for sustainable urbanization, and for a sustainable use of energy, will come from technology innovation at the borderline of different disciplines, and where semiconductor technology plays an indispensable role. That's exactly imec's strength;" said Luc Van den hove, President and CEO at imec. "To sustain our growth, we will diversify our research and offering to serve a much broader industry than we are used to work with, expanding our borders beyond the semiconductor food chain towards energy companies, medical device manufacturers, pharmaceutical companies, phone companies, wireless communications companies, display developers, and many more."
Imec performs world-leading research in nanoelectronics. Imec leverages its scientific knowledge with the innovative power of its global partnerships in ICT, healthcare and energy. Imec delivers industry-relevant technology solutions. In a unique high-tech environment, its international top talent is committed to providing the building blocks for a better life in a sustainable society. Imec is headquartered in Leuven, Belgium, and has offices in Belgium, the Netherlands, Taiwan, US, China and Japan. Its staff of about 1,900 people includes more than 500 industrial residents and guest researchers. In 2010, imec's revenue (P&L) was 285 million euro.
Imec is a registered trademark for the activities of IMEC International (a legal entity set up under Belgian law as a "stichting van openbaar nut”), imec Belgium (IMEC vzw supported by the Flemish Government), imec the Netherlands (Stichting IMEC Nederland, part of Holst Centre which is supported by the Dutch Government), imec Taiwan (IMEC Taiwan Co.) and imec China (IMEC Microelectronics (Shangai) Co. Ltd.).
For more information, please click here
External Communications Director
T: +32 16 28 18 80
Mobile: +32 474 30 28 66
Maestro Marketing & PR<
T: +1 408 996 9975
Copyright © IMECIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Better living through pressure: Functional nanomaterials made easy April 19th, 2017
UC researchers use gold coating to control luminescence of nanowires: University of Cincinnati physicists manipulate nanowire semiconductors in pursuit of making electronics smaller, faster and cheaper March 17th, 2017
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017